Proceedings of the National Academy of Sciences · 1996 · 237 citations · 24 references
Life SciencesGeneticsMolecular BiologyDna RepairGene ExpressionRna ProcessingAlternative SplicingProtein SynthesisRna InterferenceRna ModificationRna SplicingAlternative Splicing RegulationAntisense Rna RegulationAntisense RnasDisease-associated Splicing DefectsPre-messenger Rna SplicingSplice-site MutationsSplicing MutationsTransfection In Mammalian Cells
In one form of beta-thalassemia, a genetic blood disorder, a mutation in intron 2 of the beta-globin gene (IVS2-654) causes aberrant splicing of beta-globin pre-mRNA and, consequently, beta-globin deficiency. Treatment of mammalian cells stably expressing the IVS2-654 human beta-globin gene with antisense oligonucleotides targeted at the aberrant splice sites restored correct splicing in a dose-dependent fashion, generating correct human beta-globin mRNA and polypeptide. Both products persisted for up to 72 hr posttreatment. The oligonucleotides modified splicing by a true antisense mechanism without overt unspecific effects on cell growth and splicing of other pre-mRNAs. This novel approach in which antisense oligonucleotides are used to restore rather than to down-regulate the activity of the target gene is applicable to other splicing mutants and is of potential clinical interest.
24
Hematology: Basic Principles and Practice
LoAnn Peterson · American Journal of Clinical Pathology · 1995 · 520 citations